1. Home
  2. APEI vs EBS Comparison

APEI vs EBS Comparison

Compare APEI & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

APEI

American Public Education Inc.

HOLD

Current Price

$43.50

Market Cap

653.8M

ML Signal

HOLD

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

HOLD

Current Price

$11.57

Market Cap

595.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APEI
EBS
Founded
1991
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
653.8M
595.6M
IPO Year
2007
2006

Fundamental Metrics

Financial Performance
Metric
APEI
EBS
Price
$43.50
$11.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
1
Target Price
$42.43
$15.00
AVG Volume (30 Days)
204.2K
942.5K
Earning Date
03-05-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
133.01
N/A
EPS
1.30
1.35
Revenue
$654,642,000.00
$788,900,000.00
Revenue This Year
$4.89
N/A
Revenue Next Year
$6.76
$15.21
P/E Ratio
$32.03
$8.54
Revenue Growth
6.75
N/A
52 Week Low
$18.77
$4.02
52 Week High
$44.88
$14.06

Technical Indicators

Market Signals
Indicator
APEI
EBS
Relative Strength Index (RSI) 64.03 46.63
Support Level $40.80 $11.28
Resistance Level $44.88 $11.96
Average True Range (ATR) 1.79 0.68
MACD -0.06 -0.06
Stochastic Oscillator 76.50 49.75

Price Performance

Historical Comparison
APEI
EBS

About APEI American Public Education Inc.

American Public Education Inc provides online and campus based postsecondary education including various undergraduate and graduate degree programs. The fields of study include business administration, health science, technology, criminal justice, education, liberal arts, national security, military studies, intelligence, and homeland security. There are three reporting segments: the American Public University segment which is the key revenue generator; the Rasmussen University Segment and the Hondros College of Nursing segment. The revenue is generated from net course registrations and enrollment, tuition rate, net tuition, and other fees.

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

Share on Social Networks: